Literature DB >> 29485134

Breast cancer: Metronomic chemotherapy for elderly and/or frail patients.

Diana Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29485134     DOI： 10.1038/nrclinonc.2018.33

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Authors:  Hans Wildiers; Konstantinos Tryfonidis; Lissandra Dal Lago; Peter Vuylsteke; Giuseppe Curigliano; Simon Waters; Barbara Brouwers; Sevilay Altintas; Nathan Touati; Fatima Cardoso; Etienne Brain
Journal:  Lancet Oncol       Date:  2018-02-09       Impact factor: 41.316
  1 in total
  2 in total

1.  Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma.

Authors:  Ke Wu; Xiao-Qing Sun; Cai-Qin Wang; Tian-Xiao Gao; Peng Sun; Yu Wang; Wen-Qi Jiang; Zhi-Ming Li; Jia-Jia Huang
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

Review 2.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.